Research use only. DSIP is sold strictly as a reference material for in-vitro and laboratory research. Nothing here is medical advice, a sleep aid, a dosing protocol, or a statement of human efficacy — it summarises how the published literature characterises the peptide. Every batch we list is published with its independent Janoshik HPLC certificate.
What DSIP is
DSIP — Delta Sleep-Inducing Peptide — is an endogenous nonapeptide: a nine-amino-acid sequence (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) found naturally in the central nervous system. It was first isolated in the 1970s during sleep research and named for its observed association with delta-wave (slow-wave) brain activity. It is one of the more enigmatic peptides in the literature: well-characterised structurally, but with a mechanism that remains only partly understood.
Where the name comes from
The peptide was identified by Schoenenberger and Monnier in 1977, isolated from the cerebral venous blood of rabbits in a state of induced sleep. The “delta sleep-inducing” label reflects that original experimental context — its correlation with delta-frequency EEG activity — rather than a fully mapped causal pathway. That naming history matters when reading the literature: the name describes the discovery setting, not a proven function.
What the research investigates
Across the published literature, DSIP appears in several distinct research strands:
- Sleep architecture. The founding theme — effects on slow-wave (delta) sleep patterns in animal models. Results across studies are notably mixed, which is part of why the peptide is still studied.
- Stress and the HPA axis. A substantial body of work investigates DSIP’s interaction with the hypothalamic-pituitary-adrenal stress axis and corticotropin regulation.
- Thermoregulation and circadian rhythm. Several studies examine effects on body-temperature regulation and rhythm in research models.
- Antioxidant and neuroprotective activity. A separate strand looks at oxidative-stress markers and protective effects in cellular models.
What is known — and not known — about mechanism
DSIP crosses the blood-brain barrier and is found endogenously in the CNS, but the literature has not pinned it to a single, well-defined receptor in the way many peptides are. Its effects are described as modulatory and context-dependent rather than tied to one clean signalling pathway. This is the central caveat for anyone reading the DSIP literature: the data are real but heterogeneous, and the mechanism is an open research question rather than a settled fact.
How it is studied
DSIP is used as a reference peptide in neuroscience, sleep-biology, and stress-physiology research. Because the published results vary by model, species, and method, careful researchers are explicit about which experimental context a given DSIP finding comes from before generalising it.
What the literature does NOT establish
There is no validated human dosing protocol, no established human sleep or stress efficacy, and no long-term human safety data for DSIP. Reports across animal and cellular studies are inconsistent enough that “DSIP improves sleep” is not a claim the published research supports as a settled conclusion. Treat it strictly as a laboratory research compound.
Handling and reconstitution
DSIP ships as lyophilised powder and must be reconstituted before laboratory work. Reconstitution volume determines the concentration per unit, so it should be calculated rather than estimated — our peptide reconstitution guide includes a calculator and handling notes.
Verifying what you receive
The DSIP 5mg we list is published with the independent Janoshik HPLC certificate that accompanies its batch — see the lab results archive. The task ID resolves on Janoshik’s own domain, so the result is independently checkable before checkout.
Frequently asked questions
What does DSIP stand for?
Delta Sleep-Inducing Peptide. The name comes from its 1977 discovery during sleep research, where it correlated with delta-wave EEG activity — it describes the discovery context, not a proven function.
What is DSIP’s amino acid sequence?
It is a nonapeptide: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (nine amino acids), found endogenously in the central nervous system.
Does DSIP have a known receptor?
Not a single well-defined one. The literature describes its action as modulatory and context-dependent, and its precise mechanism remains an open research question.
What is DSIP researched for?
Mainly slow-wave sleep architecture, the HPA stress axis, thermoregulation/circadian rhythm, and antioxidant/neuroprotective activity — across animal and cellular models, with mixed results.
How do I verify the purity of the batch I receive?
The DSIP batch we list is published with its independent Janoshik HPLC certificate and a public verify link that resolves on Janoshik’s own domain.
Is DSIP for human use?
No. It is sold strictly as a research-use-only reference material and is not intended for human or veterinary use.
Summary
DSIP is a structurally well-defined endogenous nonapeptide with a deliberately cautious literature: real research interest across sleep, stress, and neuroprotection, but mixed results and an unsettled mechanism. Read each finding in its experimental context, reconstitute the powder correctly, and confirm the batch against its published Janoshik certificate.